Investigation of the Effect of Food and of Increased Gastric pH on the Relative Bioavailability of Deleobuvir Following Single Oral Administration in Healthy Caucasian and Japanese Subjects (an Open-label, Randomised, Four-way Crossover Study)
Phase of Trial: Phase I
Latest Information Update: 25 May 2016
Price : $35 *
At a glance
- Drugs Deleobuvir (Primary) ; Omeprazole
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 14 May 2016 Status changed from completed to discontinued.
- 22 Jan 2014 Status has gone changed from active not recruiting to completed, according to ClinicalTrials.gov record.
- 21 Nov 2013 New trial record